Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Bonate

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Analytical Biochemistry|November 15, 1988
Quantification of albumin in cerebrospinal fluidP L Bonate
Biopharmaceutics & Drug Disposition|March 1, 1995
Uptake and biodisposition of 2-ylcyanamide-1,3,4-thiadiazole (LY217896) by red blood cellsP L Bonate, A Peyton
Journal of Clinical Pharmacology|April 10, 1999
Assessment of QTc prolongation for non-cardiac-related drugs from a drug development perspectiveP L Bonate, T Russell
Journal of Clinical Pharmacology|June 27, 2000
Prospective allometric scaling: does the emperor have clothes?P L Bonate, D Howard
Journal of Clinical Pharmacology|April 13, 2000
Prospective allometric scaling: does the emperor have clothes?P L Bonate, D Howard
Clinical Pharmacokinetics|May 21, 1998
Drug interactions at the renal level. Implications for drug developmentP L Bonate, K Reith, S Weir
Pharmacology, Biochemistry, and Behavior|August 1, 1997
Behavioral sensitization to cocaine in the absence of altered brain cocaine levelsP L Bonate, A Swann, P B Silverman
Life Sciences|January 1, 1997
Context-dependent cross-sensitization between cocaine and amphetamineP L Bonate, A Swann, P B Silverman
Journal of Pharmaceutical Sciences|August 1, 1996
Preliminary physiologically based pharmacokinetic model for cocaine in the rat: model development and scale-up to humansP L Bonate, A Swann, P B Silverman
Journal of Chromatography. B, Biomedical Applications|July 21, 1995
High-performance liquid chromatographic assay for xanomeline, a specific M-1 agonist, and its metabolite in human plasmaS C Kasper, P L Bonate, A F DeLong
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Analytical Biochemistry|November 15, 1988
Quantification of albumin in cerebrospinal fluidP L Bonate
Biopharmaceutics & Drug Disposition|March 1, 1995
Uptake and biodisposition of 2-ylcyanamide-1,3,4-thiadiazole (LY217896) by red blood cellsP L Bonate, A Peyton
Journal of Clinical Pharmacology|April 10, 1999
Assessment of QTc prolongation for non-cardiac-related drugs from a drug development perspectiveP L Bonate, T Russell
Journal of Clinical Pharmacology|June 27, 2000
Prospective allometric scaling: does the emperor have clothes?P L Bonate, D Howard
Journal of Clinical Pharmacology|April 13, 2000
Prospective allometric scaling: does the emperor have clothes?P L Bonate, D Howard
Clinical Pharmacokinetics|May 21, 1998
Drug interactions at the renal level. Implications for drug developmentP L Bonate, K Reith, S Weir
Pharmacology, Biochemistry, and Behavior|August 1, 1997
Behavioral sensitization to cocaine in the absence of altered brain cocaine levelsP L Bonate, A Swann, P B Silverman
Life Sciences|January 1, 1997
Context-dependent cross-sensitization between cocaine and amphetamineP L Bonate, A Swann, P B Silverman
Journal of Pharmaceutical Sciences|August 1, 1996
Preliminary physiologically based pharmacokinetic model for cocaine in the rat: model development and scale-up to humansP L Bonate, A Swann, P B Silverman
Journal of Chromatography. B, Biomedical Applications|July 21, 1995
High-performance liquid chromatographic assay for xanomeline, a specific M-1 agonist, and its metabolite in human plasmaS C Kasper, P L Bonate, A F DeLong
Pageof 3